Author

B. Gencer

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Increased interleukin-6 levels associate with worse 1-year outcome after acute myocardial infarction and link infarct size, impaired iron status and heart failure

Interleukin 6 (IL-6) has attracted attention as a key contributor to deleterious pro-inflammatory processes in patients after acute myocardial infarction (AMI). IL-6 may also worsen heart failure (HF) by disrupting iron metabolism. However, data about IL-6 in these settings remain incomplete. To assess the...

M. A. Matter, Y.-J. Wang, V. Rossi et al. · European Heart Journal · 0 citations

Open access Oct 2026

Angiopoietin-like protein 4 identifies residual risk for atherothrombotic events in stable post-acute coronary syndrome patients: insights from the SPUM-ACS study

Angiopoietin-like protein 4 (ANGPTL4) regulates lipid metabolism and inflammation and has been linked to plaque vulnerability and thrombosis. However, its prognostic value in stable post-ACS patients is unclear, and clinical data on its association with recurrent atherothrombotic events, independent of traditiona...

K. Miteva, C. Follonier, L. Artels et al. · European Heart Journal · 0 citations

Open access Sep 2026

Interleukin-8 and other neutrophil-related biomarkers are associated with 1-year mortality in patients with acute myocardial infarction.

IL-8 and neutrophil-related biomarkers were associated with 1-year mortality in AMI patients, especially in the hyper-acute phase, and IL-8 peaked in the hyper-acute phase, earlier than high-sensitivity troponin T (hsTnT).

Yu-Jen Wang, M. A. Matter, V. A. Rossi et al. · Clinical Research in Cardiol... · 0 citations